by Francisca Peixoto | Mar 19, 2024 | Uncategorized
Our CEO and Co-founder, Francisca Peixoto, was a moderator, on March 19th, 2024, in a panel at this year’s BIO-EUROPE SPRING. The panel theme was named “In sync or offbeat: are the expectations of VCs and entrepreneurs aligned?”. This panel had the...
by Francisca Peixoto | Jan 5, 2024 | Uncategorized
As we start the new year, LifeLink Ventures releases its 2023 Annual Biotech Report. We wish to connect private investors with emerging technologies that address global health challenges. To do so, first we must bring our investors closer to the biotech world. Learn...
by Francisca Peixoto | Dec 20, 2023 | Uncategorized
Our portfolio company Eveliqure Biotechnologies announces, on December 18th 2023, that it has launched a Clinical Trial for their Shigellosis and ETEC vaccine in Bangladesh. Eveliqure is a clinical-stage Austrian biotechnology company that has developed a proprietary...
by Francisca Peixoto | Dec 7, 2023 | Uncategorized
Boston Consulting Group (BCG) made an interesting article showing #DeepTech VC funds have similar returns to traditional VC, despite the high complexity and cash needs of building hardware and #biomolecules. #DrugDevelopment has no shortage of complexity or investment...
by Francisca Peixoto | Oct 19, 2023 | Uncategorized
Our portfolio company Macomics just appointed Kevin Lee as Independent Non-Executive Director. Kevin brings over two decades of invaluable biotech and pharma experience to Macomics’ team. He has been CEO at Bicycle Therapeutics since 2015, steering the company...
